Skip to main content

News

April 27, 2021
Treatment for patients with T1 invasive breast cancer and/or breast cancer for patients not suitable for surgical alternatives included in the indications being reviewed.
April 26, 2021
ACR releases 13 new topics and five revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions
April 15, 2021
Siemens Healthineers completes acquisition of Varian, strengthening its position as a holistic partner in healthcare
March 30, 2021
Pivotal study to evaluate the use of novel liquid embolic versus standard of care in treating malignant and benign hypervascular tumors.
March 30, 2021
Fluidx Medical’s GPX™ embolic device demonstrates versatility and control in oncology clinical use.
March 25, 2021
Data presented at SIR 2021 confirm safety and dose-efficacy relationship
March 18, 2021
Treatment is the only radioembolization treatment approved for U.S. patients with hepatocellular carcinoma
March 16, 2021
Patients with debilitating bone tumors experienced improved quality of life in as little as 3 days.
March 04, 2021
NEWS PROVIDED BY GO2 Foundation for Lung Cancer  SAN CARLOS, Calif. and WASHINGTON, March 4, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the launch of an important…
March 01, 2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management
February 17, 2021
LONDON, Feb. 17, 2021 /PRNewswire/ -- Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, today announces a research collaboration with Essen University Hospital to examine…
Back to Top